Preserving the intellectual output & resources of the University of Missouri.
When should patients with stroke receive thrombolytics?
MOspace/Manakin Repository
Breadcrumbs Navigation
When should patients with stroke receive thrombolytics?
Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/3216
| Title: | When should patients with stroke receive thrombolytics? |
| Author: | Adair, Gina; Grant, Joel; Pandhi, Nancy; Saunders, Robert; Sadowsky, Iris; West, Brian; Kerns, J. William; Knight, Karen |
| Keywords: |
recombinant tissue plasminogen activator (rtPA)
treatment protocol morbidity |
| Date: | 2004-08 |
| Publisher: | Family Physicians Inquiries Network |
| Citation: | Journal of Family Practice, 53(8) 2004: 656+. |
| Abstract: | Thrombolytic therapy should be limited to patients with acute ischemic stroke who meet strict inclusion and exclusion criteria and who can adhere to strict treatment protocol. Patients treated under these conditions have improved combined mortality and disability outcomes at 1 year when treated with recombinant tissue plasminogen activator (rtPA) (number needed to treat [NNT]=18; 95% confidence interval [CI], 11-56) (strength of recommendation [SOR]: B, meta-analysis of randomized controlled trials with significant heterogeneity). |
| URI: | http://hdl.handle.net/10355/3216 |
Items in MOspace are protected by copyright, with all rights reserved, unless otherwise indicated.
This item appears in the following Collection(s)
-
Clinical Inquiries, 2004 [82]
The items in this collection constitute volume 53 of Clinical Inquiries.